Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Direct Meds vs Push Health

Direct Meds costs $701 less a month, and both sell semaglutide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Direct Meds logo

Direct Meds

6.4
★★★☆☆3.2/5

Best for: compounded semaglutide at $249/month

Visit Direct Meds →
VS
Push Health logo

Push Health

5.6
★★★☆☆2.8/5

Best for: semaglutide from $950/month

Visit Push Health →

If you are choosing between Direct Meds and Push Health, the first difference is cost: Direct Meds is $701 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Direct Meds leads our six-part score, 6.4 to 5.6. One of the two has an FDA warning letter on record, covered below.

Direct Meds vs Push Health price

Direct Meds is the cheaper way in: $249 a month against $950 a month at Push Health. That is $701 less each month (74% lower), or about $8,412 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Direct Meds ($249 a month vs $950 a month).

Medications and formats

Both sell semaglutide; only Direct Meds lists tirzepatide.

On format, Direct Meds prices compounded injections, while Push Health prices brand-name pens.

If you want the FDA-approved brand rather than a compounded version, Push Health is the only one of the two with a brand-name price.

Where each one treats patients

Neither Direct Meds nor Push Health publishes the states it serves, so enter your state at the very start of each sign-up.

Pricing

Direct Meds

SublingualCompounded
$249/mo
semaglutide

'As low as $249' per month, on a 90-day supply billed monthly; some doses run as low as $237/mo.

InjectionCompounded
$297/mo
semaglutide

'As low as $297' per month ($9.58 a day), an 84-day three-pack billed monthly.

SublingualCompounded
$299/mo
tirzepatide

'As low as $299' per month ($9.65 a day) on a 90-day supply billed monthly. Down from $399 earlier.

InjectionCompounded
$399/mo
tirzepatide

'As low as $399' per month ($12.87 a day).

Push Health

PreliminaryBrand-name
$950/mo
semaglutide

Ozempic / brand

What each price covers

Direct Meds' price also covers the clinician visit, the medication itself and shipping, which Push Health does not claim.

Direct Meds is silent on lab work and coaching.

Push Health does not say what its price includes.

That matters most for the drug: unless Push Health confirms otherwise, budget for medication on top of its listed price.

Direct Meds

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Push Health

Inclusions not disclosed.

Where each one scores higher

Overall, Direct Meds scores 6.4 and Push Health 5.6 out of 10.

Direct Meds is stronger on effectiveness (10.0 vs 9.0), user experience (8.0 vs 3.0) and support (7.0 vs 5.0).

Push Health is stronger on value (5.3 vs 3.7) and trust & safety (4.0 vs 3.5).

Accessibility is within half a point.

How we score

Direct Meds

6.4/10

Overall

Push Health

5.6/10

Value25%

3.7A
vs
B
5.3

Effectiveness25%

10.0A
vs
B
9.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

3.5A
vs
B
4.0

Accessibility10%

5.0A
vs
B
5.0

Support10%

7.0A
vs
B
5.0

FDA warning letters

The FDA sent Direct Meds a warning letter dated September 9, 2025 (letter 716822), and it is still open.

Push Health has no FDA warning letter on record with us.

Features & Coverage

FeatureDirect MedsPush Health
Starting Price✓$249/mo$950/mo
Features5 features5 features
States AvailableNot disclosedNot disclosed
Compounded✓ Yes—
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About Direct Meds

The FDA sent Direct Meds a warning letter in September 2025 over misleading marketing, and customers have reported a documented pattern of unexpected 3-month commitment charges. We list the company with both disclosed in full; read the warnings and the cons first. Its products are compounded semaglutide and tirzepatide, sold from Utah in injection and sublingual form.

Read our full Direct Meds review →

About Push Health

A 55,000+ pharmacy network sits behind Push Health, which writes brand-name GLP-1 prescriptions, Mounjaro, Zepbound, and Ozempic, and routes them through it. The platform is a large US telehealth operation and holds LegitScript certification.

Read our full Push Health review →

Pros & Cons

Direct Meds

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping

Watch-outs

  • Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $299 a month, 20% above the $250 median for compounded tirzepatide across the sellers we compare
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued Direct Meds a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Push Health

What we like

  • Semaglutide costs $950 a month, close to the $990 median for brand-name semaglutide across the sellers we compare
  • We found no FDA warning letters issued to Push Health

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Our Verdict

Winner: Direct Meds

Direct Meds wins this one, 6.4 to 5.6, above all for compounded semaglutide at $249/month. It also costs $701 less each month than Push Health. Push Health fits better if semaglutide from $950/month is your priority.

Choose Direct Meds if…

You want compounded semaglutide at $249/month and an opening price near $249 a month.

Choose Push Health if…

You want semaglutide from $950/month and an opening price near $950 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.6

Breeze Meds

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

7.7

HealthRX

Compounded semaglutide at $133/month

7.3

RNK Health

An oral route if you will not self-inject

Direct Meds vs Push Health: FAQ

Direct Meds. It starts at $249 a month; Push Health starts at $950 a month, $701 more per month.
Yes, both sell semaglutide. Direct Meds adds tirzepatide.
Direct Meds does not publish where it ships; Push Health does not publish where it ships. Confirm your state before paying.
Only Direct Meds includes the clinician visit, the medication itself and shipping.
Direct Meds has an open FDA warning letter from September 9, 2025. Push Health has none.
Direct Meds pays us a commission on sign-ups through our links; Push Health does not. Scores are computed the same way for both.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.